HCW Biologics Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
HCWB$0.94-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Index to Financial Statements
Years ended December 31, 2022 and 2023
| Audited Financial Statements | Page |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248) | 88 |
| Balance Sheets | 89 |
| Statements of Operations | 90 |
| Statements of Changes in Stockholders’ Equity | 91 |
| Statements of Cash Flows | 92 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.